<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02794623</url>
  </required_header>
  <id_info>
    <org_study_id>CRC 5583</org_study_id>
    <nct_id>NCT02794623</nct_id>
  </id_info>
  <brief_title>Tinnitus Suppression for Cochlear Implant Recipients</brief_title>
  <official_title>Evaluation of Tinnitus Suppression for Cochlear Implant Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hearing Cooperative Research Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Royal Victoria Eye and Ear Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cochlear</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>The Hearing Cooperative Research Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tinnitus is the perception of sound in the absence of an external sound. Prevalence in the&#xD;
      general population is 10 to 15%, with tinnitus severely impacting quality of life in 1-2&#xD;
      percent of the population. Tinnitus therapy is based on counselling, cognitive and&#xD;
      behavioural therapies in combination with sound therapies which mostly rely on masking.&#xD;
&#xD;
      For cochlear implant candidates, the ability to use hearing aids and maskers is limited by&#xD;
      the degree of their hearing loss. Reports of tinnitus prevalence in this group range from 67&#xD;
      to 100% with a mean of 80%.&#xD;
&#xD;
      In cochlear implant (CI) recipients, tinnitus suppression primarily occurs during active use&#xD;
      of the cochlear implant system. In some CI recipients residual inhibition of tinnitus occurs&#xD;
      when the implant is switched off. While the benefits of CI implantation on tinnitus are well&#xD;
      documented, there is a group of recipients where tinnitus remains a concern in the implanted&#xD;
      ear post-operatively.&#xD;
&#xD;
      The primary aim of this study is to investigate the benefits of using tinnitus masking via a&#xD;
      CI sound processor that optimises tinnitus suppression with minimal annoyance to the user.&#xD;
      Furthermore a questionnaire will be employed to capture the prevalence, degree and nature of&#xD;
      tinnitus in recipients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 18, 2014</start_date>
  <completion_date type="Actual">June 8, 2018</completion_date>
  <primary_completion_date type="Actual">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tinnitus Severity Questionnaire</measure>
    <time_frame>Testing over 6 months</time_frame>
    <description>Tinnitus severity questionnaire using Visual Analog Scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Word recognition scores in quiet</measure>
    <time_frame>Testing over 6 months</time_frame>
    <description>Monosyllabic word scores in quiet</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Speech recognition scores in noise</measure>
    <time_frame>Testing over 6 months</time_frame>
    <description>Sentence recognition scores in noise</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Degree of handicap as a result of tinnitus</measure>
    <time_frame>Testing over 6 months</time_frame>
    <description>Tinnitus Handicap Questionnaire used to capture degree of overall handicap as a result of tinnitus</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Tinnitus</condition>
  <arm_group>
    <arm_group_label>Cochlear Implant Recipients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tinnitus masking</intervention_name>
    <description>Tinnitus masking via CI system</description>
    <arm_group_label>Cochlear Implant Recipients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 18 years of age or older&#xD;
&#xD;
          2. Freedom or CI500 series implant&#xD;
&#xD;
          3. At least 3 months experience with the cochlear implant&#xD;
&#xD;
          4. Native speaker in the language used to assess speech perception performance&#xD;
&#xD;
          5. Willingness to participate in and to comply with all requirements of the protocol&#xD;
&#xD;
          6. Self-reported tinnitus in the implanted ear&#xD;
&#xD;
          7. Reside local to investigational site&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Signs of retrocochlear or central origin to hearing impairment as confirmed by medical&#xD;
             examination and test including MRI&#xD;
&#xD;
          2. Additional handicaps that would prevent participations in evaluations&#xD;
&#xD;
          3. Unrealistic expectations on the part of the subject, regarding the possible benefits,&#xD;
             risks and limitations that are inherent to the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The HEARing CRC</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3002</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 6, 2016</study_first_submitted>
  <study_first_submitted_qc>June 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 9, 2016</study_first_posted>
  <last_update_submitted>July 2, 2021</last_update_submitted>
  <last_update_submitted_qc>July 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cochlear implants</keyword>
  <keyword>hearing loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tinnitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

